glp-1 agonists side effects The and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy GLP-1: Genetic Variants Related to
Description
Buteau J, Foisy S, Joly E, and Prentki M
Despite the pleiotropic benefits increasingly observed for existing novel AOMs, HCPs and patients should temper enthusiasm with potential long-term adverse effects, and costs to society and healthcare systems
10.7759/cureus.39011 66 NomuraK.TakahashiK.HinomuraY.KawaguchiG.MatsushitaY.MaruiH.et al (2015)
B.GoldbergerZ
10.1016/j.hjc.2018.11.008 85
Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual -cell function
